Ironwood Pharmaceuticals | IRWD - Przychody Ze Sprzedaży

Cena Akcji
3.65
Dzienna Zmiana
0.02 0.55%
Miesięcznie
8.31%
Rocznie
463.36%
Q2 Prognozy TE
3.53




Obroty Zmiana Data
Acadia Pharmaceuticals USD 284M 5.4M 2025-12
Agios Pharmaceuticals USD 19.97M 7.07M 2025-12
Akebia Therapeutics USD 57.62M 1.14M 2025-12
Almirall EUR 547.63M 12.83M 2025-12
Alnylam Pharmaceuticals USD 1.1B 150M 2025-12
Amarin USD 49.22M 451K 2025-12
Ardelyx USD 125.21M 14.89M 2025-12
Astellas Pharma JPY 571.21B 46.89B 2025-12
AstraZeneca USD 15.5B 313M 2025-12
Charles River Laboratories USD 994.2M 5.8M 2025-12
Coherus Biosciences USD 12.75M 1.18M 2025-12
Emergent BioSolutions USD 276.6M 6.1M 2023-12
Esperion Therapeutics USD 168.45M 81.14M 2025-12
Halozyme Therapeutics USD 451.76M 97.76M 2025-12
Incyte USD 1.51B 140M 2025-12
Ironwood Pharmaceuticals USD 47.71M 74.35M 2025-12
Karyopharm Therapeutics USD 34.08M 3.54M 2025-12
Lexicon Pharmaceuticals USD 5.49M 8.69M 2025-12
MacroGenics USD 41.23M 31.61M 2025-12
Moderna USD 678M 342M 2025-12
Myriad Genetics USD 209.8M 4.1M 2025-12
Pacira USD 196.87M 17.35M 2025-12
PTC Therapeutics USD 164.7M 46.3M 2025-12
Puma Biotechnology USD 80.54M 33.46M 2024-09
Sarepta Therapeutics USD 442.9M 43.5M 2025-12
Takeda JPY 1.19T 80B 2025-12
Ultragenyx Pharmaceutical USD 207M 47M 2025-12
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12